By Karina Daiha and Andre Venturini In a recent article, we analysed a study by the Brazilian Patent Office (INPI) on the categorization of biotechnology patent…
VIPmarketingMay 3, 2019
Irisin and the patentability of new methods for treating diseases in Brazil By Karina Daiha New research led by Brazilian scientists has indicated a relationship…
VIPmarketingJanuary 31, 2019
By Julian Cornelius Earlier this month, the Brazilian Patent Office (INPI) released its latest report regarding activities in 2018. The presented figures provide grounds for…
VIPmarketingDecember 22, 2018
By Karina Daiha and Julian Cornelius In November, the Brazilian Patent Office (INPI) released a new study on the categorization of biotechnology patent documents based…
VIPmarketingDecember 6, 2018
By Andre Venturini The current position in Brazil is that any commercial, financial and accounting principle or scheme cannot receive patent protection under article 10…
VIPmarketingDecember 1, 2018
Hepatitis C: Divergent Public Opinion and Industrial Property Law in Brazil By Karina Daiha and Patrik Gandara On September 18, 2018, the National Institute…
VIPmarketingSeptember 27, 2018